PSD-95, a principal scaffolding component of the postsynaptic density, is targeted to synapses by palmitoylation, where it couples NMDA receptor stimulation to production of nitric oxide (NO) by neuronal nitric oxide synthase (nNOS). Here, we show that PSD-95 is physiologically S-nitrosylated. We identify cysteines 3 and 5, which are palmitoylated, as sites of nitrosylation, suggesting a competition between these two modifications. In support of this hypothesis, physiologically produced NO inhibits PSD-95 palmitoylation in granule cells of the cerebellum, decreasing the number of PSD-95 clusters at synaptic sites. Further, decreased palmitoylation, as seen in heterologous cells treated with 2-bromopalmitate or in ZDHHC8 knockout mice deficient in a PSD-95 palmitoyltransferase, results in increased PSD-95 nitrosylation. These data support a model in which NMDA-mediated production of NO regulates targeting of PSD-95 to synapses via mutually competitive cysteine modifications. Thus, differential modification of cysteines may represent a general paradigm in signal transduction.
INTRODUCTION
PSD-95, the principal protein of postsynaptic densities (PSD), is a major scaffolding protein that impacts synaptic plasticity (Cho et al., 1992; Migaud et al., 1998) . In addition to maintaining the molecular architecture of the PSD (Chen et al., 2008) , PSD-95 enhances long-term depression (Stein et al., 2003) and is required for spatial learning in mouse models (Migaud et al., 1998) . N-terminal palmitoylation targets PSD-95 to synapses, where it clusters AMPA-type glutamate receptors and physically links NMDA receptors to neuronal nitric oxide synthase (nNOS) (Brenman et al., 1996; Christopherson et al., 1999) . This interaction enables calcium that permeates NMDA receptors to activate nNOS by binding calmodulin associated with the enzyme (Bredt and Snyder, 1990) . Suppression of PSD-95 expression (Sattler et al., 1999) or inhibition of binding between PSD-95 and the NMDA receptor with exogenous peptides (Aarts et al., 2002) reduces NO-mediated excitotoxicity, emphasizing the role of PSD-95 in transducing signals from the NMDA receptor to nNOS.
PSD-95 also regulates AMPA receptors through its interaction with stargazin . This binding is required for recruitment of AMPA receptors to the synapse . Consistent with this observation, mice deficient in PSD-95 have decreased AMPA receptor-mediated neurotransmission (Bé ïque et al., 2006) . Furthermore, appropriate interactions between PSD-95 and A kinase-anchoring protein (AKAP) are required for NMDA-mediated AMPA receptor endocytosis (Bhattacharyya et al., 2009) .
PSD-95 function is regulated by dynamic cycling of palmitoylation and depalmitoylation . Glutamate receptor activation enhances depalmitoylation of PSD-95 (ElHusseini et al., 2002) , while blockade of synaptic activity enhances PSD-95 palmitoylation through regulated translocation of the dendritic palmitoyl acyltransferase (PAT) DHHC2 (Noritake et al., 2009) . Palmitoylation influences synaptic dynamics by augmenting clustering of PSD-95 at dendritic spines (Craven et al., 1999) .
Palmitoylation of PSD-95 takes place at cysteines 3 and 5 (Topinka and Bredt, 1998) . Nitric oxide signals in large part by S-nitrosylating (hereafter referred to as ''nitrosylating'') cysteines in a variety of proteins (Hess et al., 2005) . Hess et al. (1993) showed that NO donors can inhibit the palmitoylation of several proteins in dorsal root ganglia neurons and suggested that a NO-mediated posttranslational modification might compete with palmitoylation. Because of its close physical proximity to both the NMDA receptor and nNOS, we wondered whether PSD-95 might be a target for nitrosylation and whether there might be some interaction between putative nitrosylation and palmitoylation of PSD-95. In the present study we show that PSD-95 is physiologically nitrosylated at cysteines 3 and 5 in a reciprocal relationship with palmitoylation. This process impacts the physiologic clustering of PSD-95 at synapses.
RESULTS

PSD-95 Is Physiologically Nitrosylated at Cysteines 3 and 5
We examined the possibility that PSD-95 can be nitrosylated by exposing HEK293 cells containing overexpressed PSD-95 to the NO donor cysteine-NO (Cys-NO) ( Figure 1A ). The NO donor elicits nitrosylation of PSD-95, monitored by the biotin-switch assay, in a concentration-dependent fashion. To determine whether PSD-95 is physiologically nitrosylated in mammalian brain, we monitored endogenous PSD-95 in mouse brain from wild-type and nNOS-deleted animals ( Figure 1B ). We observe ascorbate-dependent basal nitrosylation of endogenous PSD-95 that is abolished in nNOS knockout mice. Levels of nitrosylated PSD-95 are comparable to those of the NR2A subunit of the NMDAR ( Figure 1C) . PSD-95 is palmitoylated at cysteines 3 and 5 (Topinka and Bredt, 1998) . These occur in the N-terminal 60% of the protein, which contains the three PDZ domains that are sufficient for synaptic targeting in the context of endogenous PSD-95 expression (Craven et al., 1999; Sturgill et al., 2009) . While PSD-95 contains six cysteines, only two of these (C3 and C5) occur in the N-terminal fragment (amino acids 1-433), which we designate PSD-95-1-433. We observe similar levels of nitrosylation for full-length PSD-95 and PSD-95-1-433 in HEK-nNOS cells ( Figure 1D ). In HEK-nNOS cells nitrosylation of PSD-95-1-433 is abolished with mutation of both C3 and C5 with intermediate effects in the individual C3 and C5 mutants ( Figure 1E ).
Palmitoylation of PSD-95 Is Physiologically
Regulated by NO Because PSD-95 is palmitoylated and nitrosylated at the same cysteines, we wondered whether the two processes might be mutually competitive. Consistent with this hypothesis, stable overexpression of nNOS in HEK293 cells substantially diminishes palmitoylation of full-length PSD-95 as measured by [ 3 H]palmitate incorporation ( Figure 2A ). Inhibition of nNOS in these cells by the nNOS-selective inhibitor N5-(1-imino-3-butenyl)-L-ornithine (L-VNIO) increases PSD-95 palmitoylation, while transient expression of nNOS in 293 cells reduces PSD-95 palmitoylation when measured directly by the acyl biotin exchange (ABE) procedure (Figures 2B and 2C) . This method is analogous to the biotin-switch method but uses hydroxylamine to reverse palmitoylation (Drisdel et al., 2006) .
To confirm that NO is the mediator of these effects, we treated 293 cells with Cys-NO, which markedly reduces [ 3 H]palmitate incorporation into PSD-95 ( Figure 2D ). NO donor treatment similarly reduces palmitoylation of PSD-95-1-433. The action of NO upon PSD-95 palmitoylation is selective. Thus, HRas is physiologically palmitoylated and nitrosylated, but the two processes occur at different sites of the protein (Hancock et al., 1989; Lander et al., 1996) . NO donor treatment fails to alter palmitoylation of HRas ( Figure 2E ). We explored the influence of NO upon palmitoylation of PSD-95 in mammalian brain. In both cerebellar granule and hippocampal cultures, palmitoylation, monitored with [ 3 H]palmitate, is virtually abolished by NO donor treatment ( Figures 3A and 3B ) concomitant with increases in PSD-95 nitrosylation ( Figures 3C and 3D) .
We wondered whether endogenous NO regulates palmitoylation of PSD-95 in the brain. Because nNOS is highly expressed in granule cells of the cerebellum, we chose to focus on this system. Utilizing the ABE assay in cerebellar granule cells, we detect robust palmitoylation of endogenous PSD-95, which is significantly enhanced by treatment with L-VNIO ( Figure 3E ). Thus, endogenous NO physiologically diminishes levels of PSD-95 palmitoylation. Blocking synaptic activity with tetrodotoxin (TTX) increases palmitoylation of several proteins including PSD-95 (Hayashi et al., 2009; Noritake et al., 2009 ). Nitrosylation of PSD-95 is decreased and palmitoylation increased in neurons treated with TTX ( Figures 3F and 3G) .
NMDAR-mediated neurotransmission is known to stimulate NO formation (Bredt and Snyder, 1989) . We conducted experiments to assess its impact on palmitoylation. NMDA treatment of granule cells reduces palmitoylation of PSD-95 by $70% ( Figure 2H ). This action reflects NMDA augmentation of NO formation, as it is largely reversed by treatment with L-VNIO. Moreover, we observe reciprocal changes in PSD-95 nitrosylation, suggesting that nitrosylation is responsible for the effects of NMDA-mediated NO formation ( Figure 3I ). To further explore the importance of endogenous NO in regulating PSD-95 palmitoylation, we made use of nNOS-deleted mice ( Figure 3J ). We confirm the marked reduction of PSD-95 palmitoylation in response to NMDA treatment. Levels of PSD-95 palmitoylation are significantly augmented in nNOS-deleted granule cells both in the absence and presence of NMDA treatment ( Figure 3J ). NMDA does elicit some decrease in PSD-95 palmitoylation in nNOS knockout mice, which may reflect the retention of alternatively spliced, catalytically active nNOS (Eliasson et al., 1997) or compensatory mechanisms involving eNOS or iNOS (Huang and Fishman, 1996) . Thus, diverse experimental approaches establish that in mammalian brain, endogenous NO under basal conditions and in response to NMDAR-mediated neurotransmission regulates the palmitoylation of PSD-95.
Synaptic Clustering of PSD-95 Is Inhibited by NMDA Transmission in a NO-Dependent Fashion
One of the principal roles of PSD-95 palmitoylation is to regulate synaptic clustering of the protein. Thus, synaptic clustering of PSD-95 is abolished with C3 and C5 mutation, which prevents palmitoylation (Craven et al., 1999) . Moreover, inhibition of palmitoylation with 2-bromopalmitate (2-BP) reduces PSD-95 synaptic clusters . Bredt, Nicoll, and Fukata established that glutamate neurotransmission, acting via ionotropic receptors, diminishes PSD-95 clustering both by inhibiting palmitoylation (Noritake et al., 2009 ) and by stimulating depalmitoylation . We wondered whether this process might involve influences of NO acting by displacing palmitate from PSD-95. Accordingly, we examined the effect of NMDA treatment upon PSD-95 clustering in cerebellar granule neurons and evaluated the influence of the nNOS inhibitor VNIO (Figure 4 ). PSD-95 is synaptic in localization as it is closely apposed to clusters of synapsin, a presynaptic marker, with statistically significant colocalization (Pearson correlation coefficient, 0.45) ( Figure 4A ). NMDA treatment reduces PSD-95 synaptic clusters by $40%, while VNIO significantly reverses this action. In contrast, synapsin clusters are unchanged. The partial reversal by VNIO may indicate that the NMDA effects involve other signaling systems in addition to NO, possibly associated with calcium entering cells through NMDA channels. Double labeling is specific, as demonstrated by omission of primary antibodies ( Figure 5C ). As previously reported, 2-BP reduces PSD-95 clustering ( Figures 5A and 5B). Palmitoylation of PSD-95 regulates basal AMPA receptor clustering . Addition of NMDA to cultured neurons triggers AMPA receptor endocytosis (Beattie et al., 2000) . Treatment with 2-BP does not further decrease GluR2 surface clusters in neurons exposed to NMDA ( Figures 4C and  4D ), suggesting that palmitoylated targets including PSD-95 play a role in both basal and NMDA-dependent AMPA receptor surface clustering.
These experiments establish that NMDAR-mediated neurotransmission regulates PSD-95 clustering. The reduction of PSD-95 clustering in response to glutamatergic transmission involves NO. The regulation of PSD-95 clustering by NO reflects its influence upon palmitoylation of PSD-95.
Palmitoylation Physiologically Regulates Nitrosylation of PSD-95
Nitrosylation is increasingly appreciated as a major posttranslational modification of proteins (Cho et al., 2009; Hess et al., 2005; Whalen et al., 2007) . Besides nitrosylation and palmitoylation, cysteines of proteins are physiologically modified by oxidative mechanisms involving hydrogen peroxide and other agents, as well as by glutathionylation, sulfhydration, and the formation of disulfide bonds. With the exception of disulfides (Takahashi et al., 2007) , thus far there has been no evidence for physiologic regulation of nitrosylation by these other posttranslational modifications of cysteines. We asked whether palmitoylation might normally modulate levels of nitrosylated PSD-95. In HEK-nNOS cells nitrosylation of PSD-95-1-433 is demonstrable and is lost with mutation of C3 and C5 ( Figure 6A ). Nitrosylation of PSD-95-1-433 is substantially augmented by treatment with 2-BP, indicating that endogenous palmitoylation reduces levels of PSD-95 nitrosylation. This reciprocity of nitrosylation and palmitoylation is selective. Thus, b-tubulin is known to be nitrosylated ) but has not been conclusively shown to be palmitoylated in vivo. Nitrosylation of tubulin is unaffected by 2-BP.
To assess whether endogenous palmitoylation of PSD-95 physiologically regulates its nitrosylation in intact animals, we examined brains of mice with targeted deletion of the palmitoyl acyltransferase enzyme ZDHHC8, which has been demonstrated to be a physiologic PAT for PSD-95 (Mukai et al., 2008) (Figure 6B ). Levels of nitrosylation of PSD-95 are increased 3-fold in the ZDHHC8 knockout brains. By contrast, nitrosylation of GAPDH, which is not physiologically palmitoylated, is unaltered in the mutant mice. The proportionally larger increase in nitrosylation of PSD-95 compared to palmitoylation may be due to higher levels of palmitoylated PSD-95 in unstimulated brains with low basal levels of NO. A small change in palmitoylation may therefore result in a larger percentage change in nitrosylation of PSD-95. Neither palmitoylation (Hayashi et al., 2009 ) nor nitrosylation (Choi et al., 2000) of NR2A, which occurs on distinct cysteines, is affected in the mutant mice ( Figure 6C ). Thus, nitrosylation of PSD-95 is physiologically modulated by palmitoylation.
NO is known to regulate NMDA receptors in a feedback fashion, inhibiting their function by nitrosylating them (Choi et al., 2000) . PSD-95 serves as a conduit for NMDA receptors to activate nNOS, generating NO (Christopherson et al., 1999) . We wondered whether the generated NO might feed back to regulate palmitoylation of PSD-95 through nitrosylation. Accordingly, we examined the binding of NR2B to PSD-95 in mice with ZDHHC8 deletion to determine whether higher levels of nitrosylated PSD-95 present in these mutant mice are associated with decreased NR2B-PSD-95 binding ( Figure 6D ). This binding is substantially reduced in the mutant mice. While deficient palmitoylation and mislocalization of PSD-95 may be involved in the decreased binding (Li et al., 2003) , our results are consistent with the hypothesized feedback model.
DISCUSSION
NO is well established as a modulator of synaptic transmission throughout the brain (Bredt, 1999) . PSD-95, the principal component of postsynaptic densities, is a scaffolding protein that influences synaptic transmission. PSD-95 binds nNOS, facilitating the linkage of NMDAR-mediated neurotransmission to activation of nNOS by calcium that passes through NMDA ion channels (Christopherson et al., 1999; Sattler et al., 1999) . Heretofore, there has been no evidence for any reciprocal influence of NO upon PSD-95. Our study provides compelling (H) NMDA decreases PSD-95 palmitoylation in an NO-dependent manner. Cerebellar granule cells were treated with 300 mM NMDA and 10 mM glycine in ACSF for 10 min with or without 1 hr of 75 mM VNIO pretreatment, returned to normal media for 8 hr, and analyzed by ABE. Shown are a representative result (left) and quantification (right), analyzed as in (E). Data are means ± SEM (n = 3). *p < 0.02 relative to NMDA treated. (I) NMDA elicits PSD-95 nitrosylation in an NO-dependent manner. Nitrosylation of PSD-95 in cerebellar granule cells was measured by the biotin-switch assay after treatment with NMDA and/or VNIO as in (H). (J) Increased PSD-95 palmitoylation in nNOSÀ/À cultures. Cerebellar granule cells derived from either wild-type or nNOSÀ/À mice were treated with NMDA as in (H) and analyzed by ABE. Shown are a representative result (top) and quantification (bottom), analyzed as in (E). Data are means ± SEM (n = 4). *p < 0.05 relative to untreated wild-type mice; #p < 0.02 relative to wild-type mice + NMDA.
evidence that NO physiologically nitrosylates PSD-95. Synaptic clustering of PSD-95, a process that determines its influence upon synaptic transmission, is critically dependent upon its palmitoylation (Craven et al., 1999) . Our observation that nitrosylation and palmitoylation of PSD-95 are reciprocal events indicates that NO normally impacts major functions of PSD-95. We also observed that palmitoylation physiologically regulates nitrosylation of PSD-95. and palmitoylation (Figure 7 ). Glutamate-NMDA neurotransmission leads to depalmitoylation of PSD-95 as reported by . Calcium entering cells via the NMDA ion channel binds to calmodulin associated with nNOS, causing NO formation. Generated NO nitrosylates PSD-95 in a process competitive with palmitoylation, blocking free cysteines and maintaining PSD-95 in the depalmitoylated state. Augmented NMDA transmission and associated NO formation thereby lead to decreased palmitoylation of PSD-95. We have also shown that this regulation is reciprocal. While NO inhibits palmitoylation, endogenous palmitoylation also regulates nitrosylation of PSD-95. We demonstrate that deletion of a PSD-95 PAT, ZDHHC8, results in increased nitrosylation of PSD-95 concomitant with a decrease in binding of PSD-95 and NR2B. It is unknown whether or not ZDHHC8 has activity toward NR2B. Thus the potential contribution of altered NR2B palmitoylation in the ZDHHC8À/À mouse to decreased binding with PSD-95 remains to be clarified. ZDHHC8 is primarily localized in a perinuclear domain and in dendritic shafts of mature neurons with partial colocalization with PSD-95 at these sites (Mukai et al., 2004 (Mukai et al., , 2008 .
Several depalmitoylating enzymes have been described, including APT1 and PPT1 (Fukata and Fukata, 2010) . None of them has been shown to act upon PSD-95 directly. Thus, their role in regulating PSD-95 palmitoylation is unclear. Conceivably such depalmitoylating enzymes might act in conjunction with NO to influence the state of palmitoylation of PSD-95.
The modulation of PSD-95 palmitoylation by glutamatergic transmission is reversed by CNQX, a drug that blocks AMPA receptors, and by AP5, an inhibitor of NMDA receptors, as well as by kynurenic acid, which blocks both ionotropic glutamate receptors . From these limited experiments one cannot assess the relative contribution of various subtypes of ionotropic glutamate receptors to the palmitoylation process. Moreover, there are no data available regarding the impact of metabotropic glutamate transmission upon PSD-95 palmitoylation. Our experiments emphasize the role of NMDA transmission in PSD-95 palmitoylation. Clarification of the detailed interaction of various types of glutamate transmission in influencing the counterbalance of NO and palmitoylation for regulation of PSD-95 awaits further investigation.
There is precedent for competing posttranslational modifications influencing protein function, most notably with acetylation and ubiquitination (Ge et al., 2009; Giandomenico et al., 2003; Grö nroos et al., 2002) . Thus, the dynamic reciprocity between palmitoylation and nitrosylation of PSD-95 may reflect a process that occurs with other proteins that are nitrosylated and palmitoylated at the same sites. Nitrosylation is a very common posttranslational modification affecting more than 100 proteins (Hess et al., 2005) . Palmitoylation is similarly prevalent with at least 68 proteins in mammalian brain known to be palmitoylated plus an additional 200 candidates recently found in a proteomic screen (Kang et al., 2008) . We are not aware of other studies in which reciprocal nitrosylation and palmitoylation have been characterized for individual proteins at the same sites. Because of the large numbers of proteins that are nitrosylated and/or palmitoylated, we suspect that interactions between these two processes are frequent and that they mediate numerous physiologic processes both in the brain and periphery.
Sulfhydration, a posttranslational modification elicited by the gasotransmitter actions of H 2 S (Mustafa et al., 2009 ) also might influence PSD-95. H 2 S signaling via sulfhydration differs in some respects from nitrosylation. A more stable modification, sulfhydration often activates proteins, because the SH becomes an even more reactive SSH, while nitrosylation often inactivates a reactive cysteine by converting the reactive SH to SNO. Whether putative sulfhydration of PSD-95 would functionally alter the protein differently from nitrosylation is unclear.
PSD-95 exerts its physiologic effects by binding to a variety of protein partners. Conceivably, nitrosylation of PSD-95 affects such binding. For instance, AKAP links PSD-95 to AMPA receptor endocytosis (Bhattacharyya et al., 2009) interactions with AKAP and provide another means of linking NMDA and AMPA receptors. Similarly, stargazin, which is physiologically nitrosylated (Selvakumar et al., 2009 ), binds to PSD-95 as well as AMPA receptors. Nitrosylation of PSD-95 might influence its binding to stargazin and thereby to AMPA receptors. Nitrosylation of stargazin facilitates its augmentation of the surface expression of AMPA receptors (Selvakumar et al., 2009) . One might speculate that NMDA transmission would enhance nitrosylation of both PSD-95 and stargazin with complex influences upon AMPA receptor disposition.
EXPERIMENTAL PROCEDURES
Cell Culture HEK293 and HEK-nNOS cells were cultured in DMEM with 10% FBS, 2% penicillin-streptomycin, 2 mM L-glutamine, and 8 g/ml tylosin (Sigma-Aldrich). Dissociated granule cells were prepared from mouse cerebellum as described (Kato et al., 2007) and plated at a density of 5 3 10 6 cells/6 cm dish. Dissociated hippocampal neurons were prepared from E18 mice as described (Kang et al., 2010) . For NMDA treatments prior to ABE analysis, cells with or without 1 hr of L-VNIO pretreatment were stimulated with 300 mM NMDA and 10 mM glycine for 10 min in ACSF (10 mM HEPES, 10 mM D-glucose, 2 mM CaCl 2 , 3 mM KCl, and 124 mM NaCl, pH 7.4) and returned to growth media for 8 hr. For basal L-VNIO treatments, 75 mM L-VNIO was added to growth media for 8 hr.
Antibodies and Reagents
Antibodies were purchased from the following companies: PSD-95 (7E3-1B8) was from Millipore for biochemistry, with the exception of Figure 3G , where PSD-95 (6G6 1C9, Millipore) was used. PSD-95 (MA1-046) was from Affinity Bioreagents for immunostaining; GADPH was from Santa Cruz (rabbit); NR2B (ZK11) was from Invitrogen for immunoprecipitation; and synapsin (H-170) was from Santa Cruz. FLAG M2 and conjugated beads were from Sigma and anti-GFP agarose was from MBL. NR2B and NR2A antibodies for western blotting (C-terminal) were generous gifts from Richard Huganir. L-VNIO was from Alexis and NMDA and 2-bromopalmitate were from Sigma.
Plasmids and Transfections pgW.1-PSD-95-FLAG was a generous gift from David Bredt. Cysteine mutants and pgW.1-PSD-95-1-433-FLAG were generated by using standard protocols for Phusion DNA polymerase (Finnzymes, Thermo Fisher Scientific). mEGFP-HRAS (Addgene plasmid 18662) was purchased from Addgene (Yasuda et al., 2006) . Plasmids were transfected by using polyfect (QIAGEN) following the manufacturer's instructions. For all experiments, cells were lysed 24 hr after transfection.
Biotin-Switch Assay
Cell extracts or homogenates from age-matched mouse brain samples were analyzed by the biotin-switch assay as described with minor modifications . Briefly, 293 cells at 95% confluency or cerebellar granule cells seeded at 1 3 10 7 cells per dish were extracted in HEN buffer (250 mM HEPES, 1 mM EDTA, and 0.1 mM neocuproine, pH 7.7) containing 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, and 200 mM desferoxamine, with protease and phosphatase inhibitors (Sigma). Extracts were treated with methylmethanethiosulfonate (Sigma) in 2.5% SDS at 50 C for 20 min. Proteins were precipitated with acetone and labeled with biotin-HPDP (0.8 mM) (Pierce) with or without 50 mM ascorbate for 90 min at room temperature. Proteins were precipitated twice with acetone and biotinylated proteins were purified by using neutravidin beads (Pierce), separated by SDS-PAGE, and analyzed by western blotting.
Metabolic Labeling with [ 3 H]Palmitate
[ 3 H]palmitate was purchased from NEN and concentrated by using a Speedvac. Cells were labeled in PBS with 0.1 mCi/ml palmitate (293 cells) or 0.5 mCi/ml palmitate in ACSF (neurons). Lysis was performed in modified RIPA buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, and 0.1% SDS) and proteins of interest were immunoprecipitated with the appropriate antibody overnight followed by a 2 hr incubation with protein A/G-conjugated agarose (Calbiochem). Proteins were eluted at 70 C in NuPage sample buffer (2 3) (Invitrogen) containing 1 mM DTT and separated on SDS-PAGE. For experiments with 293 cells, gels were stained with SimplyBlue (Invitrogen); for neuronal experiments, 10% of each eluate was western blotted for input controls. Gels for fluorography were soaked in Amplify (Amersham) for 30 min, dried under vacuum at 70 C, and exposed for 3-4 days (overexpressed protein) or 3-4 weeks (endogenous protein).
ABE Assay
Cell extracts or homogenates from age-matched brain samples were analyzed by the acyl-biotin exchange assay as described with minor modifications (Wan et al., 2007) . Briefly, cells were lysed in buffer containing 50 mM Tris, 50 mM NaCl, 1 mM EDTA, and 2% SDS, supplemented with protease inhibitors. Extracts were sonicated briefly and treated with 10 mM NEM for 20 min at 37 C. Proteins were precipitated with acetone and labeled with biotin-HPDP (0.8 mM) in buffer containing either 0.56 M hydroxylamine, pH 7.4, or 0.56 M Tris, pH 7.4, for 1 hr at room temperature. Proteins were run through a Zeba desalting column (Pierce) followed by acetone precipitation. Biotinylated proteins were purified with neutravidin beads (Pierce), separated by SDS-PAGE, and analyzed by western blotting.
Immunostaining and Image Analysis
Neurons were seeded at a density of 1 3 10 6 cells/well onto polylysine coated
Lab-Tek two-well chamber slides. At DIV 12, samples were treated with While palmitoylated (red wavy lines), PSD-95 is stably associated with the PSD (orange region). NMDA stimulation promotes depalmitoylation through a putative palmitoyl protein thioesterase (PPT) . Simultaneously, calcium entering cells through the NMDA ion channel activates nNOS by binding to calmodulin, causing NO formation. NO generated in close proximity to PSD-95 nitrosylates PSD-95, blocking free cysteines and preventing repalmitoylation by PSD-95 PATs and subsequent association with the PSD.
100 mM NMDA in ACSF for 10 min with or without 100 mM VNIO pretreatment for 1 hr and were returned to normal media for 8 hr. Cells were fixed in 4% paraformaldehyde for 20 min, blocked in 5% goat serum with 0.1% Triton X-100 in PBS for 1 hr, and stained overnight at 4 C for PSD-95 (1:200) or synapsin
(1:100) in blocking solution. Appropriate secondary antibodies conjugated to AlexaFluor 488 and 567 (Molecular Probes) were incubated with samples for 1 hr at room temperature after three washes with TBST. Slides were prepared by using Fluormount G (Southern Biotech) and images were taken with a Zeiss 510 Meta confocal microscope at 63 3. Analysis of PSD-95 clusters was performed as described (Mukai et al., 2008) . Briefly, the particle measurement function of ImageJ was used to count discrete fluorescent puncta in a proximal 20 mM section of the largest one or two dendrites per neuron. Settings of minimal punctum size and threshold were maintained constant across all treatment conditions. Pearson's coefficients were calculated by using the colocalization threshold plugin for ImageJ.
Analysis of GluR2 Surface Clustering
Hippocampal neurons were treated with and without 20 mM 2-bromopalmitate for 8 hr. For live staining, neurons (DIV 15) were incubated with 50 mg/ml antiGluR2 N-terminal antibody (Millipore) in conditioned medium for 15 min at 37 C. Neurons were fixed with 4% PFA for 10 min on ice, blocked in 5 mg/ml bovine serum albumin in PBS for 10 min, and stained with secondary antibody under unpermeabilized conditions. Neurons were then permeabilized to detect the antigen. Images were taken with a confocal laser microscopy system (Carl Zeiss LSM 510; Carl Zeiss). The number of GluR2 fluorescent puncta, which are merged with VGLUT1, was calculated as surface GluR2 by using ImageJ. To quantitate changes in clustering, we chose twelve fields from two independent neuronal cultures and analyzed the largest proximal dendrite (30 mm long).
Coimmunoprecipitation
Proteins from brain homogenate were extracted with modified RIPA buffer and incubated with anti-NR2B antibody (Invitrogen) overnight followed by a 2 hr incubation with protein A/G agarose-conjugated beads (Calbiochem). Beads were washed three times in modified RIPA, aspirated to dryness with a syringe, eluted with 2 3 LDS, and analyzed by SDS-PAGE.
